3D Medicines Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	170.24	444.32	666.47	696.74	774.31
Short-Term Investments	168.29	227.15	120.78	136.68	-
Trading Asset Securities	99.38	169.52	209.33	108.6	50.18
Cash & Short-Term Investments	437.91	840.98	996.58	942.03	824.48
Cash Growth	-47.93%	-15.61%	5.79%	14.26%	99.02%
Accounts Receivable	20.71	47.86	5.46	78.04	65
Other Receivables	0.08	75.54	79.54	76.63	7.29
Receivables	22.13	127.09	85	155.91	72.29
Inventory	3.51	4.06	4.61	1.2	0.01
Restricted Cash	-	-	-	-	0.07
Other Current Assets	93.68	15.62	8.97	43.93	22.37
Total Current Assets	557.23	987.75	1,095	1,143	919.23
Property, Plant & Equipment	137.6	147.73	193.25	177.84	118.54
Long-Term Investments	87.08	23.34	70.59	-	-
Other Intangible Assets	0.52	0.63	0.73	0.83	0.93
Other Long-Term Assets	153.81	56.82	11.89	6.02	17.18
Total Assets	936.24	1,216	1,429	1,332	1,060
Accounts Payable	89.18	51.13	71.9	15.88	3.74
Accrued Expenses	-	164.3	124.35	183.83	111.18
Short-Term Debt	-	195.59	174.37	103.99	-
Current Portion of Long-Term Debt	136.5	9	27	-	3,094
Current Portion of Leases	9.83	8.27	23.23	11.31	12.75
Current Income Taxes Payable	-	1.8	1.91	-	1.43
Current Unearned Revenue	-	-	24.54	-	-
Other Current Liabilities	149.41	57.69	53.08	61.24	24.98
Total Current Liabilities	384.92	487.79	500.37	376.25	3,248
Long-Term Debt	-	16.5	29.24	27	38.82
Long-Term Leases	6.45	8.25	28.58	33.4	45.99
Total Liabilities	391.37	512.54	558.2	436.65	3,333
Common Stock	0.23	0.23	0.23	0.22	0.06
Additional Paid-In Capital	-	4,785	4,785	4,228	134.66
Retained Earnings	-	-4,343	-4,161	-3,636	-2,612
Treasury Stock	-0.01	-0.17	-0.01	-0.03	-0.03
Comprehensive Income & Other	596.51	343.22	311.97	350.98	239.02
Total Common Equity	596.73	785.06	936.74	943	-2,238
Minority Interest	-51.85	-81.35	-66.05	-47.59	-34.55
Shareholders' Equity	544.87	703.71	870.69	895.41	-2,273
Total Liabilities & Equity	936.24	1,216	1,429	1,332	1,060
Total Debt	152.78	237.62	282.43	175.7	3,192
Net Cash (Debt)	285.13	603.36	714.15	766.33	-2,367
Net Cash Growth	-52.74%	-15.51%	-6.81%	-	-
Net Cash Per Share	1.16	2.46	3.13	16.85	-60.61
Filing Date Shares Outstanding	245.89	244.97	245.07	224.2	36.45
Total Common Shares Outstanding	245.89	244.97	245.07	224.2	36.45
Working Capital	172.31	499.96	594.78	766.81	-2,329
Book Value Per Share	2.43	3.20	3.82	4.21	-61.40
Tangible Book Value	596.2	784.44	936.01	942.17	-2,239
Tangible Book Value Per Share	2.42	3.20	3.82	4.20	-61.43
Machinery	-	9.58	8.28	8.06	7.06
Construction In Progress	-	112.02	112.02	99.87	28.16
Leasehold Improvements	-	31.16	35.09	33.16	23.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.